Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 301 - 350 out of 3,590

Document Document Title
WO/2008/067911
The invention relates to new compounds of the formula (I) in which W, X, Y, Z and CKE have the meanings given above, to a plurality of processes and intermediates for their preparation and to their use as pesticides and/or herbicides, an...  
WO/2008/061871
The present invention relates to ketomethionine ketals or hemiketals and their derivatives and also their preparation and their use as fodder additives, in particular for the nutrition of ruminants.  
WO/2008/061821
The present invention relates to a process for preparing tetramethyl glycolide, in which a composition comprising at least 50% by weight of 2-hydroxyisobutyric acid and/or tetramethyl glycolide is heated to a temperature of at least 100°C.  
WO/2008/058402
The invention is directed to compounds and methods for treating protein folder disorders. In certain embodiments the invention provides compounds and methods for treating neurodegenerative diseases such as Alzheimer's disease, tauopathy,...  
WO/2008/052086
Compounds are described herein which are agonists or partial agonists of the 2C subtype of brain serotonin receptors. The compounds have the formula I: or pharmaceutically acceptable salts thereof, wherein each of A, R1, R2, R3, R4, Ra, ...  
WO/2008/047651
Disclosed is a process for producing flake-like dried DOG. In the process, DOG having a liquid content of 10 to 50 mass% is subjected to a continuous melting/drying step under specific conditions. The resulting product is subjected to a ...  
WO/2008/043947
The invention relates to a method for the synthesis of cyclic acetals that comprises reacting at least one carbonyl-function compound selected from aldehydes, ketones and/or linear acetals, on a polyol in a concentrated aqueous solution ...  
WO/2008/031157
The present invention relates to a class of acetylenic compounds, to a method of preparing the acetylenic compounds, and to the polymerisation and therapeutic uses of the acetylenic compounds. The invention particularly relates to compou...  
WO/2008/016199
The present invention relates to a process for the preparation of chiral 2-hydroxymethyl-l,4-benzodioxane compound. The method in accordance with the present invention comprises the steps of reacting chiral epihalohydrin or chiral glycid...  
WO/2008/015885
Disclosed is a method for purifying a hydroxycarboxylic acid by distillation, which is characterized by distilling an aqueous hydroxycarboxylic acid solution containing a high boiling point hydroxy compound which is composed of at least ...  
WO/2008/011742
A method of using organic compounds and providing slow release flavoring in or for food products wherein flavor precursors are added to flavor compositions and/or food products and release flavor compounds upon consumption of the food pr...  
WO/2008/012950
Disclosed are: a composition useful for the detoxification of a toxic compound containing arsenic or the like efficiently and systematically; and a method for the detoxification of a toxic compound using the composition. Specifically, di...  
WO/2008/013550
Novel substituted phenylsulfur trifluorides that act as fluorinating agents are disclosed. Also disclosed are methods for their preparation and methods for their use in introducing one or more fluorine atoms into target substrate compounds.  
WO/2008/010455
Disclosed is a method for producing a β-diaryl electron-withdrawing group substituted compound at high yield with high selectivity. Specifically, an optically active β-diaryl electron-withdrawing group substituted compound represented ...  
WO/2008/007780
Disclosed is a pentadienamide derivative represented by the formula (I) or a pharmaceutically acceptable salt thereof or the like. (I) wherein R1 represents a substituted or unsubstituted aryl or a substituted or unsubstituted aromatic h...  
WO/2008/006860
This invention describes the preparation of fatty acid esters of glycerol formal either by a triglyceride transesterification process or, alternatively, by an esterification process of fatty acids previously obtained from the hydrolysis ...  
WO/2007/148975
The invention relates to a method for the purification or recovery of lactide rich streams by the combination of a suspension-based melt crystallization process with a subsequent separation of the pure lactide crystals in a wash column.  
WO/2007/148975
The invention relates to a method for the purification or recovery of lactide rich streams by the combination of a suspension-based melt crystallization process with a subsequent separation of the pure lactide crystals in a wash column.  
WO/2007/139062
[PROBLEMS] To provide a prophylactic and therapeutic agent for obesity which has a more effective and potent efficacy and has reduced adverse side-effects, and also provide a method for prevention and treatment of obesity. [MEANS FOR SOL...  
WO/2007/138485
1,3-dioxane derivatives are described and their use in the treatment of a disease or condition dependent on PPAR modulation, such as diabetes, cancer, inflammation, neurodegenerative disorders and infections.  
WO/2007/138485
1,3-dioxane derivatives are described and their use in the treatment of a disease or condition dependent on PPAR modulation, such as diabetes, cancer, inflammation, neurodegenerative disorders and infections.  
WO/2007/139998
The present invention provides methods for preparing a compound of formula D having activity as dopamine autoreceptor agonist and partial agonists at the postsynaptic dopamine D2 receptor. This compound is useful for treating dopaminergi...  
WO/2007/139998
The present invention provides methods for preparing a compound of formula D having activity as dopamine autoreceptor agonist and partial agonists at the postsynaptic dopamine D2 receptor. This compound is useful for treating dopaminergi...  
WO/2007/136790
Intracellular kinase inhibitors and their therapeutic uses for patients with T cell malignancies, B cell malignancies, autoimmune disorders, and transplanted organs.  
WO/2007/136790
Intracellular kinase inhibitors and their therapeutic uses for patients with T cell malignancies, B cell malignancies, autoimmune disorders, and transplanted organs.  
WO/2007/133751
A stabilized semi-solid delivery vehicle contains a polyorthoester and an excipient, and a pharmaceutical composition contains an active agent, optionally a stabilizing agent, and the delivery vehicle. The pharmaceutical composition may ...  
WO/2007/133751
A stabilized semi-solid delivery vehicle contains a polyorthoester and an excipient, and a pharmaceutical composition contains an active agent, optionally a stabilizing agent, and the delivery vehicle. The pharmaceutical composition may ...  
WO/2007/127309
Provided are processes for the synthesis of 3-isobutylglutaric acid, an intermediate in the synthesis of (S)-Pregabalin.  
WO/2007/127309
Provided are processes for the synthesis of 3-isobutylglutaric acid, an intermediate in the synthesis of (S)-Pregabalin.  
WO/2007/123942
The present invention relates to methods for synthesizing compounds of formula (I) or pharmaceutically acceptable salts thereof: Formula (I) wherein each of R1, R2, R3, R4, x, m, n, and Ar are as defined, and described in classes and sub...  
WO/2007/123942
The present invention relates to methods for synthesizing compounds of formula (I) or pharmaceutically acceptable salts thereof: Formula (I) wherein each of R1, R2, R3, R4, x, m, n, and Ar are as defined, and described in classes and sub...  
WO/2007/115968
Provided is a process for the preparation of 2(R)-(3-chloro-4-methanesulfonyl-phenyl)-3-((R)-3-oxocyclope ntyl)-N-pyrazin-2-ylpropionamide of formula (I) and its isopropanol solvate as a glucokinase activator which increases insulin secr...  
WO/2007/115968
Provided is a process for the preparation of 2(R)-(3-chloro-4-methanesulfonyl-phenyl)-3-((R)-3-oxocyclope ntyl)-N-pyrazin-2-ylpropionamide of formula (I) and its isopropanol solvate as a glucokinase activator which increases insulin secr...  
WO/2007/114213
[PROBLEMS] To provide a compound capable of inhibiting the production of a prostaglandin or leukotriene. [MEANS FOR SOLVING PROBLEMS] Disclosed is a compound represented by the general formula (I) or a salt thereof: (I) wherein (a) repre...  
WO/2007/107276
The present invention relates to a process for preparing C7 intermediates and their use in the preparation of pyrrole derivatives of a class that is effective at inhibiting the biosynthesis of cholesterol in humans, and more particularly...  
WO/2007/107276
The present invention relates to a process for preparing C7 intermediates and their use in the preparation of pyrrole derivatives of a class that is effective at inhibiting the biosynthesis of cholesterol in humans, and more particularly...  
WO/2007/099553
The present invention relates to novel 1,3-dioxane carboxylic acids of the general formula (I), their tautomeric forms, their stereoisomers, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, methods fo...  
WO/2007/099553
The present invention relates to novel 1,3-dioxane carboxylic acids of the general formula (I), their tautomeric forms, their stereoisomers, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, methods fo...  
WO/2007/096261
The present invention is concerned with a novel process for the preparation of compounds of formula (I), wherein R1 and R2 are as defined in the description and claims. The compounds of formula (I) are pharmaceutically active substances.  
WO/2007/096261
The present invention is concerned with a novel process for the preparation of compounds of formula (I), wherein R1 and R2 are as defined in the description and claims. The compounds of formula (I) are pharmaceutically active substances.  
WO/2007/083640
[PROBLEMS] To provide a drug which has a selective β3 receptor activating effect and is useful in preventing or treating increased urinary frequency and urinary incontinence. [MEANS FOR SOLVING PROBLEMS] It is disclosed that 6-[2-(R)-[(...  
WO/2007/074776
The invention aims at providing a simple and easy method by which many kinds of organic chemicals (contaminants) can be efficiently decomposed in a short time and separated and recovered as insoluble matter. Water or soil contaminated wi...  
WO/2007/069773
The present invention provides a novel modulator of the TRPV1-receptor function, comprising a compound of the formula; wherein ring A is an optionally substituted carbocycle or heterocycle, ring B is an optionally substituted benzene rin...  
WO/2007/069777
Conventional fungicidal compositions have had practical problems such that either a preventive effect or a curative effect is inadequate, the residual effect tends to be inadequate, or the controlling effect against plant diseases tends ...  
WO/2007/069777
Conventional fungicidal compositions have had practical problems such that either a preventive effect or a curative effect is inadequate, the residual effect tends to be inadequate, or the controlling effect against plant diseases tends ...  
WO/2007/068330
The present invention relates to 2-adamantylurea derivatives of formula (I) as selective inhibitors of the enzyme 11-beta-hydroxysteroid dehydrogenase type 1 (11β-HSD1) and the use of such compounds for the treatment and prevention of m...  
WO/2007/063925
Disclosed is a novel and excellent therapeutic or prophylactic agent for nociceptive pain, neuropathic pain, cancer pain, headache, bladder dysfunction or the like, which relies on a preventive activity on capsaicin receptor VR1 activati...  
WO/2007/057703
Process for the preparation of statins, in particular atorvastatin via intermediates of Formula (1) and a process for the preparation of said intermediates.  
WO/2007/057703
Process for the preparation of statins, in particular atorvastatin via intermediates of Formula (1) and a process for the preparation of said intermediates.  
WO/2007/051762
The invention relates to a process for producing trioxane and at least one comonomer for producing (co)polymers on a trioxane basis, in which, in a first step, formaldehyde and at least one comonomer starting material are reacted in aque...  

Matches 301 - 350 out of 3,590